Evidence map›Paper›PMID 39291284›Full record

ArticleOpen medicine (Warsaw, Poland)2024

Paraquat disrupts the blood-brain barrier by increasing IL-6 expression and oxidative stress through the activation of PI3K/AKT signaling pathway.

Tao Liu, Fenshuang Zheng, Lin Liu, Hua Zhou, Tao Shen, Yanping Li, Wei Zhang

Abstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tao LiuDepartment of Emergency Medicine, Affiliated Hospital of Yunnan University, Kunming, 650000, Yunnan, China.
Fenshuang ZhengDepartment of Emergency Medicine, Affiliated Hospital of Yunnan University, Kunming, 650000, Yunnan, China.
Lin LiuDepartment of Emergency Medicine, Affiliated Hospital of Yunnan University, Kunming, 650000, Yunnan, China.
Hua ZhouDepartment of Emergency Medicine, People's Hospital of Yuxi City, Yuxi, 653100, Yunnan, China.
Tao ShenDepartment of Emergency Medicine, People's Hospital of Gejiu City, Gejiu, 661000, Yunnan, China.
Yanping LiDepartment of Emergency Medicine, People's Hospital of Gejiu City, Gejiu, 661000, Yunnan, China.
Wei ZhangDepartment of Emergency Medicine, Affiliated Hospital of Yunnan University, No. 176, Youth Road, Kunming, 650000, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Paraquat (PQ) is a frequently used herbicide with neurotoxic effects after acute or chronic exposure. Although Methods: Adult male Sprague Dawley rats and primary human brain microvascular endothelial (PHBME) cells were exposed to PQ as the animal and cell models. Evans Blue staining and hematoxylin & eosin staining were conducted to examine the BBB and brain tissue damages. The inflammatory cytokines were quantified via enzyme linked immunosorbent assay. The changes of PI3K/AKT signaling pathway were detected by western blot. Results: PQ exposure can cause significant pathological lesions in the brain tissues and the BBB. IL-6 and reactive oxygen species levels were found to be significantly upregulated after PQ exposure in both the animal and cell models. PQ treatment could arrest the cell proliferation and migration in PHBME cells. PQ treatment promoted the phosphorylation of PI3K and AKT, and the application of PI3K inhibitor could attenuate PQ-induced IL-6 production, oxidative stress, BBB disruption, and brain tissue damage. Conclusion: Our study demonstrated that chronic PQ exposure could impair the BBB function and induce brain tissue damage. The overactivation of the PI3K/AKT pathway, consequent upregulation of IL-6 production, and increased oxidative stress appear to mediate the inflammatory damage resulting from PQ exposure.

Indexed as

BBBIL-6inflammation.paraquatPI3K/AKT signaling

Identifiers

PMID39291284
PMCPMC11406143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.